Deals

The latest pharma deals — mergers, acquisitions, licensing agreements, and partnerships shaping the business of drug development worldwide.

Lilly
Biotech

Lilly’s $2.3B Ajax drug works ‘right out of the gate’

The early data showed the novel JAK2 inhibitor “started working right out of the gate, with a good safety profile,” Lilly’s Jake Van Naarden said.
Angus Liu Jun 13, 2026 11:15am
glue scissors art supplies

Novartis sticks 2nd deal with Orionis, this one worth up to $1.4B

Jun 10, 2026 8:21am
AlzeCure

Lilly licenses AlzeCure Alzheimer’s asset for $1B biobucks

Jun 9, 2026 10:16am
Concepts of medical examination and study of intestine microflora

Galmed buys Colospan in $4.5M deal as it eyes $6B GI dx market

Jun 9, 2026 8:01am
Miels

GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer

Jun 9, 2026 4:41am
forest

Treeline sees path to public markets via reverse merger

Jun 8, 2026 10:37am